Ahmed El Ray

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

Tarik Asselah, Simon De Muynck, Philippe Broët et al. · Journal of Hepatology · 2011 · 182 citations

Medicine, Immunology, Pharmacology +14

Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin†

Michelle Martinot‐Peignoux, Christiane Stern, Sarah Maylin et al. · Hepatology · 2009 · 175 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy

Rami Moucari, Marie–Pierre Ripault, Valérie Oulès et al. · Journal of Hepatology · 2006 · 56 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Egyptian recommendations for management of Helicobacter pylori infection: 2018 report

Mohamed Alboraie, Walied Elhossary, Osama Aboelfotoh Aly et al. · Arab Journal of Gastroenterology · 2019 · 34 citations

Pharmacy, Infectious Diseases, Microbiology +7

Insulin resistance

Ahmed El Ray, Tarik Asselah, Rami Moucari et al. · European Journal of Gastroenterology & Hepatology · 2013 · 15 citations

Medicine, Endocrinology, Physiology +3